Pyridine → tert-Butyl 2-(2-(4-(hydroxyimino)-6-(methylsulfonamido)spiro[chroman-2,4'-piperidine]-1'-yl)ethoxy)ethylcarbamate
반응식
N1C=CC=CC=1.Cl.[NH2:8][OH:9].[CH3:10][S:11]([NH:14][C:15]1[CH:16]=[C:17]2[C:40](=[CH:41][CH:42]=1)[O:39][C:20]1([CH2:25][CH2:24][N:23]([CH2:26][CH2:27][O:28][CH2:29][CH2:30][NH:31][C:32](=[O:38])[O:33][C:34]([CH3:37])([CH3:36])[CH3:35])[CH2:22][CH2:21]1)[CH2:19][C:18]2=O)(=[O:13])=[O:12]>CO.ClCCl>[OH:9][N:8]=[C:18]1[C:17]2[C:40](=[CH:41][CH:42]=[C:15]([NH:14][S:11]([CH3:10])(=[O:13])=[O:12])[CH:16]=2)[O:39][C:20]2([CH2:25][CH2:24][N:23]([CH2:26][CH2:27][O:28][CH2:29][CH2:30][NH:31][C:32](=[O:38])[O:33][C:34]([CH3:35])([CH3:36])[CH3:37])[CH2:22][CH2:21]2)[CH2:19]1참가 물질
반응물 3
생성물 1
시약·촉매·용매 2
실험 절차
Anhydrous pyridine (40 μL, 0.5 mmol) and hydroxylamine hydrochloride (8 mg, 0.11 mmol) were added to a solution of tert-butyl 2-(2-(6-(methylsulfonamido)-4-oxospiro[chroman-2,4′-piperidine]-1′-yl)ethoxy)ethylcarbamate (12, 50 mg, 0.10 mmol) in 5 mL of anhydrous methanol. This solution was stirred at room temperature for ˜1 hour and then at ˜60° C. for ˜1 hour. Additional hydroxylamine hydrochloride (6.2 mg, 0.09 mmol) and anhydrous pyridine (40 μL, 0.5 mmol) were added and stirring was continued at 60-65° C. for ˜1 hour. More hydroxylamine hydrochloride (13.9 mg, 0.20 mmol) was added and stirring was continued at 60-65° C. for ˜80 minutes. Hydroxylamine hydrochloride (7 mg, 0.10 mmol) was added and stirring was continued at 60-65° C. for ˜2 hours. TLC (silica gel, 10% methanol in dichloromethane, UV visualization) showed complete disappearance of starting ketone 12 (Rf=0.35-0.4) and a single new spot (18, Rf=0.18-0.27). The reaction mixture was concentrated to dryness under reduced pressure on a rotary evaporator. The residue was dissolved in 5 mL of ethyl acetate and extracted successively with 10 mL of 0.5 M aqueous hydrochloric acid, mL of water, and 5 mL of saturated aqueous sodium chloride. TLC (as above) showed the product (18) in the combined aqueous extracts, which were adjusted to pH ˜13 by addition of sodium hydroxide pellets and then to pH ˜4 by addition of 3 M aqueous hydrochloric acid. The aqueous solution was extracted with three 20 mL portions of ethyl acetate. The combined ethyl acetate extract was dried over anhydrous sodium sulfate, filtered, and evaporated to dryness under reduced pressure on a rotary evaporator followed by high vacuum overnight to afford 50.3 mg (98% yield) tert-butyl 2-(2-(4-(hydroxyimino)-6-(methylsulfonamido)-spiro[chroman-2,4′-piperidine]-1′-yl)ethoxy)ethylcarbamate (18).
후처리
- waitat ˜60° C. for ˜1 hour
- stirringstirring
- waitwas continued at 60-65° C. for ˜1 hour
- stirringstirring
- waitwas continued at 60-65° C. for ˜80 minutes
- stirringstirring
- waitwas continued at 60-65° C. for ˜2 hours
- concentrationThe reaction mixture was concentrated to dryness under reduced pressure on a rotary evaporator
- dissolutionThe residue was dissolved in 5 mL of ethyl acetate
- extractionextracted successively with 10 mL of 0.5 M aqueous hydrochloric acid, mL of water, and 5 mL of saturated aqueous sodium chloride
- additionwere adjusted to pH ˜13 by addition of sodium hydroxide pellets
- additionto pH ˜4 by addition of 3 M aqueous hydrochloric acid
- extractionThe aqueous solution was extracted with three 20 mL portions of ethyl acetate
- extractionThe combined ethyl acetate extract
- dry with materialwas dried over anhydrous sodium sulfate
- filtrationfiltered
- customevaporated to dryness under reduced pressure on a rotary evaporator
- customfollowed by high vacuum overnight
출처 및 근거
- ORD 기록
- ord-669940a7a1774e27831541decd22b631
- 출처 데이터셋
- uspto-grants-2012_03
- 특허 번호
- US08133695B2
반응 노트
불러오는 중…